Aghaei Gharehbolagh S, Nasimi M, Agha Kuchak Afshari S, Ghasemi Z, Rezaie S
Department of Medical Mycology and Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Curr Med Mycol. 2017 Jun;3(2):33-37. doi: 10.18869/acadpub.cmm.3.2.33.
(formerly ) is a non-neoformans cryptococcal species rarely isolated as a human pathogen.
Herein, we present the case of a 26-year-old Iranian man with a superficial cutaneous lesion in the axilla. The initial treatment for pityriasis versicolor by clotrimazole was unsuccessful. We performed skin sampling based on the standard protocol and conducted further investigations by the conventional laboratory tests and molecular analysis of the skin samples. All the mentioned analyses revealed as the causative agent of infection. The minimum inhibitory concentration (MIC) analysis was carried out for the isolated agent, and the patient was treated using 100 mg daily of oral itraconazole.
can be the causative agent of some superficial infections. This is the first report on the successful detection and treatment of a superficial skin infection due to by oral itraconazole.
(以前称为)是一种非新型隐球菌的隐球菌属物种,很少作为人类病原体分离出来。
在此,我们报告一例26岁伊朗男性腋窝浅表皮肤病变的病例。使用克霉唑治疗花斑糠疹的初始治疗未成功。我们按照标准方案进行了皮肤采样,并通过常规实验室检测和皮肤样本的分子分析进行了进一步调查。所有上述分析均显示为感染的病原体。对分离出的病原体进行了最低抑菌浓度(MIC)分析,并给予患者每日口服100毫克伊曲康唑进行治疗。
可成为某些浅表感染的病原体。这是关于口服伊曲康唑成功检测和治疗由引起的浅表皮肤感染的首例报告。